For most of my career, pathology lived at the microscope. Diagnosis, differential, sign-out, and repeat. It was rigorous, technical, and intellectually satisfying. Yet, over time, something felt incomplete. The cases were sound, but the surrounding systems – workflow delays, test overuse, communication gaps, and chronic resource constraints – kept intruding into daily practice.
Pursuing a Master in Business Administration (MBA) degree did not pull me away from pathology; it forced me to look more closely at everything surrounding it.
First, I applied my MBA training to my approach to laboratory work itself. I stopped viewing cases as isolated diagnostic problems and began seeing them as part of a production system – with inputs, constraints, handoffs, and predictable failure points. Turnaround time was no longer just a number on a dashboard. Mapping a week of cases made it clear that many delays had little to do with diagnostic difficulty and everything to do with batching habits, unclear ownership, leadership issues, or extraneous steps that no one had questioned for years. Errors, similarly, appeared less as individual lapses and more as expected outcomes of poorly designed processes.
That systems-focused mindset quickly translated into daily practice. Grossing protocols became more deliberate. Sampling strategies were aligned more closely with clinical decision-making rather than routine. Immunohistochemistry was ordered with clearer intent and guided by diagnostic yield and downstream impact instead of reflex. None of this reduced diagnostic rigor. If anything, it sharpened it. The MBA mindset reinforced a lesson medicine often resists: efficiency and quality are not opposing goals but are frequently the same problem viewed from different angles.
Strategic thinking was the next shift. In pathology, uncertainty often triggers expansion for more stains, broader panels, additional hedging. Management training introduced a different question: what decision will this test enable, and what happens if it does not? In a resource-limited public hospital setting, this question matters. Diagnostic thoroughness must coexist with stewardship. The MBA skill set provided a framework to justify selective, evidence-based testing, not as cost-cutting, but as value creation. It changed how those decisions were explained to clinicians, and how they were defended when questioned.
Leadership and communication shifts followed, sometimes uncomfortably. Pathologists often sit between clinical urgency and institutional constraint, yet are trained to absorb friction quietly. That posture became harder to maintain. I became more deliberate about defining roles, setting boundaries, and escalating system-level issues instead of compensating for them personally. Reports became clearer and more purposeful. Recommendations were framed around clinical pathways rather than academic completeness. At times, this made conversations harder, and occasionally unpopular, but it also made them more honest.
Taking a fresh look at healthcare economics – often viewed warily by physicians – proved unexpectedly clarifying. Understanding cost structures, reimbursement logic, and revenue integrity illuminated pathology’s quiet but decisive role in hospital function. A laboratory decision can determine whether a patient undergoes surgery, stays another night, or is discharged. Seeing that made pathology less invisible and more strategic. It also reframed discussions about investment in technology, staffing, and training, not as expenses to justify, but as enablers of institutional performance.
Perhaps the most profound impact of the MBA course was temporal. Medical training conditions us to think in the immediate – today’s list, today’s frozen section, today’s call. Management training stretches the horizon. I began to think more deliberately about workforce pipelines, retention of trained staff, succession planning, and the sustainability of subspecialty services. Teaching and mentorship took on a different weight, not merely as academic duties, but as strategic assets. The question shifted from “Who can sign this out today?” to “What kind of pathology service will still function well five to ten years from now?”
Importantly, management training did not make pathology less clinical. It made it more accountable. Decisions now carry an explicit awareness of trade-offs, time versus certainty, breadth versus depth, speed versus safety. This awareness does not weaken judgment, but disciplines it. It replaces intuition alone with reasoning that can be explained, defended, and improved.
There is a persistent fear that management education dilutes medical identity. My experience was the opposite. It stripped away the assumption that good intentions can compensate for weak systems. It demanded that expertise translate into outcomes, not just correctness. In doing so, it reaffirmed why pathology matters, not only because diagnoses are accurate, but because they arrive on time, are understood, and meaningfully guide care.
I still practice pathology at the microscope. But I also practice it in workflows, policies, training programs, and strategic discussions. As pathology becomes more central to clinical decision-making and more constrained by workforce shortages, rising complexity, and limited resources, the way we practice can no longer rely on individual effort alone. It must be designed.
Management training did not turn me into an administrator who happens to be a doctor. It made me a pathologist who understands how diagnostic expertise is delivered at scale, sustained over time, and protected from avoidable failure. That perspective matters as laboratories confront growing demands for speed, accuracy, integration, and accountability.
The future of pathology will not be defined solely by new technologies or expanded test menus, but by how well we build systems that allow those tools to deliver value safely and consistently. In that future, the pathologist’s role extends beyond interpretation to stewardship, leadership, and design. Thinking beyond the microscope is no longer optional. It is part of practicing pathology for what comes next.
Newsletters
Receive the latest pathologist news, personalities, education, and career development – weekly to your inbox.
